HCPCS code A4236: Silver oxide battery billing guide

Key Takeaways

HCPCS code A4236 is a replacement silver oxide battery for a patient-owned home blood glucose monitor, billed one unit per battery

It sits in a four-code battery family, A4233 through A4236, split only by chemistry; A4237 was never assigned, and A4238 is a separate CGM supply-allowance code, not a fifth battery option

Claims need modifier KX or KS depending on the beneficiary’s insulin status, plus KL when the battery ships by mail; KF, the FDA Class III modifier, does not apply to this code

Refill batteries only go out after the supplier contacts the beneficiary and confirms the need, per the glucose monitor LCD, not on a pre-set mail-order schedule

Practice management software like Pabau keeps the physician order, delivery proof, and patient history organized in one client record, so the paperwork is easy to find at claim time

HCPCS code A4236 pays for a silver oxide battery for a patient’s own home blood glucose monitor, nothing else. Get the chemistry and the modifier right, and this is one of the simplest DMEPOS claims a supplier files.

The trouble is the code sits inside a four-code family that differs only by battery chemistry, next to two look-alike neighbors, A4237 and A4238, that don’t belong in it at all. Mix up the chemistry, reach for the wrong modifier, or lump A4238 in with the rest, and a two-minute refill claim turns into a denial.

Here’s what actually distinguishes A4236, and how to bill it clean the first time.

What HCPCS code A4236 actually covers

The official long descriptor is exact: Replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each.

CMS assigned A4236 effective January 1, 2006, as part of the HCPCS Level II code set maintained by CMS. Its short descriptor, used on remittance advice and some claims systems, reads “Silvr oxide batt glucose mon.”

A4236 falls under the DMEPOS program, so only a CMS-accredited DMEPOS supplier can bill it to Medicare, the same enrollment requirement that applies to the monitor itself, its test strips, and adjacent supplies such as A4206.

Because the code describes the battery’s chemistry and its use, not a brand or model, the same code applies across manufacturers as long as the meter takes a silver oxide cell.

The A4233-A4236 battery series, and where A4237 and A4238 don’t belong

All four codes in this family do the exact same job, a battery for a patient-owned home blood glucose monitor, split only by chemistry. Confirm the meter’s power source before selecting a code; billing the wrong chemistry is the fastest way to trigger a code-to-device mismatch denial.

Two codes that look like they belong in this family don’t. A4237 was never assigned, CMS’s HCPCS files run A4233, A4234, A4235, A4236, then skip straight to A4238, so a claim or crosswalk referencing A4237 is referencing a code that doesn’t exist.

A4238 does exist, but it’s a different benefit entirely, a supply allowance for an adjunctive, non-implanted continuous glucose monitor, bundling the sensors and accessories that a CGM needs into one unit of service. It has nothing to do with a discrete battery, and it shouldn’t be billed alongside A4233 through A4236 as if it were a fifth chemistry option.

Need the alkaline or lithium version instead? A4233 and A4235 walk through the coverage and modifier rules for the other two chemistries in this same family.

Medicare coverage and eligibility for A4236

Medicare covers A4236 under the DME benefit once three things line up: the beneficiary has a diagnosed condition, typically diabetes, that requires home blood glucose monitoring, the beneficiary already owns a covered home blood glucose monitor, and a supplier has a valid order on file.

Skip any one of the three and the battery claim gets denied, no matter how correctly A4236 itself is coded.

• The beneficiary has a diagnosed condition, most often diabetes managed through a metabolic health or weight-loss practice, requiring home glucose monitoring, supported by an ICD-10 diagnosis in the record
• The home blood glucose monitor itself already meets Medicare’s own coverage criteria; a battery for a device Medicare hasn’t approved isn’t separately payable
• A treating physician or qualified prescriber has issued a standard written order (SWO) naming the battery chemistry and quantity
• The supplier is an enrolled, CMS-accredited DMEPOS supplier
• The refill request comes from the beneficiary or their authorized representative, confirmed by the supplier before dispensing, never shipped automatically on a schedule
• Quantity stays within the DME MAC’s published frequency limit for the supply period

The governing documents are the Glucose Monitor LCD (L33822) and its companion Policy Article (A52464), and they should be read together. Interpretation can vary slightly by DME MAC jurisdiction, so check the specifics with Noridian or CGS Medicare, whichever contractor processes your claims, before submitting.

Documentation Medicare wants on file before you bill A4236

Missing documentation, not a coding mistake, is what drives most glucose monitor improper payments in CMS’s own audit data. For A4236, the supplier’s file needs:

• Standard written order (SWO): naming the battery chemistry (silver oxide) and the quantity authorized per supply period
• Proof of monitor ownership: confirmation the beneficiary owns a home blood glucose monitor that already meets Medicare’s coverage criteria
• A documented refill request: the supplier has to contact the beneficiary and get an affirmative response before dispensing a refill battery, not ship on autopilot
• Signed proof of delivery
• Current CMS DMEPOS supplier accreditation on file

Structured medical forms and documentation workflows make it easier to keep the SWO, the ownership proof, and the delivery record together in one client record instead of scattered across separate systems. The same habits behind clear nursing documentation apply just as much to keeping DMEPOS paperwork claim-ready.

Modifiers that actually belong on an A4236 claim

Three modifiers show up on A4236 claims, and none of them is optional once its condition is met. A fourth, KF, gets applied out of habit by suppliers used to billing continuous glucose monitor codes, and it doesn’t belong here at all.

KF, the FDA Class III device modifier, does not apply to A4236. CMS’s glucose monitor policy restricts KF to continuous glucose monitor codes and their supply allowance, not to a standard home blood glucose monitor or its battery, which aren’t Class III devices.

Appending KF to an A4236 claim anyway doesn’t just risk an edit, it signals to the MAC that the supplier is confusing two different benefit categories.

How an A4236 claim moves, and where it breaks

Before you submit

1. Confirm the beneficiary’s monitor model and check the chemistry the manufacturer specifies. Silver oxide points to A4236, not A4233, A4234, or A4235.
2. Verify a standard written order is on file naming the chemistry and quantity, and that it predates the claim.
3. Confirm this is a genuine refill request from the beneficiary or their representative, not an automatic reship, and document who made it.
4. Select KX or KS based on the beneficiary’s insulin status, and add KL if the battery is shipping rather than being handed over in person.
5. Check the unit count against the supply period’s frequency limit and the code’s MUE (2 units) before submitting.

The mistakes that trigger denials

• Wrong chemistry code: billing A4236 for a battery the monitor’s own manual specifies as lithium or alkaline is a straightforward device mismatch.
• Missing KX or KS: Medicare requires one of the two on every claim; a claim with neither denies automatically.
• Appending KF: the Class III modifier belongs to CGM codes, not this battery family, and it doesn’t help the claim.
• Shipping refills without a beneficiary-initiated request: an autoship battery program looks efficient and gets denied as not reasonable and necessary.
• Treating A4238 as a fifth option in this series: it’s a CGM supply allowance, a separate benefit, not a battery code.

A4236 fee schedule and reimbursement

A4236 doesn’t price the way most DMEPOS supply codes do. Since 2013, CMS has paid A4233 through A4236, along with the related diabetic testing-supply codes swept into the same national mail-order program, at a single, nationally equalized rate rather than a locality-adjusted amount.

Whether the claim carries the KL mail-order modifier or not, the underlying payment rate for the battery itself doesn’t change by state or county the way most DME supply pricing does.

• Check the current-year CMS DMEPOS fee schedule file before billing; rates update annually.
• The CMS Physician Fee Schedule Look-Up Tool doesn’t return DMEPOS supply pricing, it’s built for RVU-based physician services, not this code, so use the DMEPOS fee schedule file or your DME MAC’s own pricing tool (Noridian or CGS) instead.
• The code’s MUE caps a single date-of-service claim at 2 units; documentation supports going over that, a bigger order alone doesn’t.
• Commercial and Medicaid rates are set separately, check the payer contract or state fee schedule.

Keep diabetic supply documentation organized with Pabau

Pabau keeps the physician order, delivery proof, and patient history organized in one client record, so documentation for diabetic supply codes like HCPCS A4236 is easy to find at claim time. See how it fits your workflow.

Book a demo

Conclusion

HCPCS code A4236 is one of the simpler DMEPOS codes to get right, once you know it’s a glucose monitor battery, not an implant accessory. The chemistry has to match the device, the modifier has to match the beneficiary’s insulin status, and the refill has to be requested, not scheduled.

Pabau keeps the physician order, the delivery signature, and the patient’s history organized in one client record, so none of the supporting paperwork needs reconstructing after a denial.

To see how Pabau keeps diabetic-supply documentation organized, book a demo with the team.

Continue your research

Stocking the alkaline version instead? A4233 covers the same battery job for monitors that take an alkaline cell rather than silver oxide.

Billing the lithium option? A4235 walks through the modifier and documentation rules for the lithium battery in this same family.

Also billing test strips for the same patient? A4253 covers the testing-supply side of the same glucose monitor coverage rules.

Frequently asked questions